Dupilumab and nasal lining in chronic sinusitis with polyps
Treatments studied
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This study tests whether dupilumab, a medication given as an injection, helps improve the lining of the nose in people with chronic sinus inflammation and nasal polyps. If you have nasal polyps and are about to start dupilumab, or if you have sinusitis without polyps, you may be eligible to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic sinus inflammation (chronic rhinosinusitis)
- If you have nasal polyps, you are planning to start treatment with dupilumab
- You are not pregnant or breastfeeding
- You do not have cystic fibrosis or primary ciliary dyskinesia
- You have not had a sinus flare-up in the past 4 weeks, and you haven't taken steroid pills for your sinus condition in the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how dupilumab (an injection medicine) helps people with chronic rhinosinusitis with nasal polyps, including how well it works across different ethnic backgrounds. You may be able to join if you’ve been diagnosed and you can get dupilumab through insurance or a patient assistance program.
This study is testing if a drug called Dupilumab affects your immune system when you have both asthma and nasal polyps and are having sinus surgery. It might help doctors understand how to better treat these conditions together.
This trial studies whether dupilumab can improve smell in adults whose nasal polyps are causing long-lasting smell loss. It may help learn how well the treatment restores smell, so future patients can benefit sooner.
This trial tests if patients with chronic sinusitis and nasal polyps can safely reduce how often they take their biologic medication (dupilumab or mepolizumab) after their disease has been partly controlled for at least a year.
This trial tests a new antibody medicine (CM326) for people with chronic sinusitis and nasal polyps whose symptoms persist despite standard treatments like nasal sprays. It aims to see if the drug can reduce inflammation and improve symptoms.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.